Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy

Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy

US Patent 11919946 · Granted Mar 5, 2024

Estimated economic value: $67,065,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for improving the efficacy and expansion of immune cells2025
Treatment of cancer using humanized anti-BCMA chimeric antigen receptor2025
Method of redirecting t cells to treat HIV infection2024
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy2024
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy2024
Treatment of cancer using GFR alpha-4 chimeric antigen receptor2024
Compositions and methods of muscle specific kinase chimeric autoantibody recepto2024
Methods for improving the efficacy and expansion of chimeric antigen receptor-ex2024
Methods and compositions for cells expressing a chimeric intracellular signaling2024
Methods and compositions for cells expressing a chimeric intracellular signaling2023
Treatment of cancer using a CD123 chimeric antigen receptor2023
Compositions and methods of chimeric autoantibody receptor T cells2023